Crossmark

Sesame oil improves biomarkers of glycemic control in women with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, controlled clinical trial

Crossref DOI link: https://doi.org/10.1186/s40795-025-01123-0

Published Online: 2025-07-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Atefi, Masoumeh https://orcid.org/0000-0003-3984-166X
Vahedi, Hamid https://orcid.org/0000-0002-3482-3457
Darand, Mina https://orcid.org/0000-0003-2636-0963
Entezari, Mohammad Hassan https://orcid.org/0000-0003-4321-4124
Funding

Funding for this research was provided by:

Isfahan University of Medical Sciences (399632)
License Information

Text and Data Mining valid from 2025-07-05

Version of Record valid from 2025-07-05
More Information

Article History

Received: 18 November 2024

Accepted: 27 June 2025

First Online: 5 July 2025

Declarations

:

: This study was approved by the Institutional Review Board of Isfahan University of Medical Sciences (code: IR.MUI.RESEARCH.REC.1399.548). All procedures involving human participants were conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All study protocols were thoroughly explained to the participants, and written informed consent was obtained from each participant prior to their inclusion in the study. Participants were assured that their participation was voluntary and that they could withdraw from the study at any time without consequences.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below